Stakeholders are increasingly turning to data monitoring committees for better oversight.
Barbara Schneider, PhD, MBA
Advertisement
Executive Director of Biostatistical Services, Advarra
Articles by Barbara Schneider, PhD, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Honing the Power of AI for Next Generation Trial Oversight and Execution
2
A Look Back: AI and Pragmatic Trials Took Center Stage at SCOPE Summit 2025
3
Genentech’s Phase III MEERKAT and SANDCAT Trials Show Vision and Anatomical Gains With Vamikibart in Uveitic Macular Edema
4
ACT Brief: AI-Driven Oversight, Biotech Acceleration Strategies, and a Major Win in Bladder Cancer
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
